Limat, S <br/><br/>
Incidence and risk-factors of CHOP/R-CHOP-related cardiotoxicity in patients with aggressive non-Hodgkin's lymphoma.  [electronic resource] 

 -  Journal of clinical pharmacy and therapeutics  Apr 2014 
 - 168-74 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1365-2710 
<br/><br/><label>Standard No.: </label>10.1111/jcpt.12124  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Murine-Derived--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cardiotonic Agents--therapeutic use<br/>Cyclophosphamide--adverse effects<br/>Dexrazoxane--therapeutic use<br/>Doxorubicin--adverse effects<br/>Female<br/>Heart Failure--chemically induced<br/>Humans<br/>Incidence<br/>Kaplan-Meier Estimate<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Prednisone--adverse effects<br/>Retrospective Studies<br/>Risk Factors<br/>Rituximab<br/>Vincristine--adverse effects<br/>Young Adult